Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Cancer Type

Gastrointestinal 1

Conditions

Breast Neoplasms 37 Melanoma 17 Prostatic Neoplasms 16 Lung Neoplasms 14 Neoplasms 13 Squamous Cell Carcinoma of Head and Neck 10 Neoplasm Metastasis 9 Carcinoma, Non-Small-Cell Lung 9 Precancerous Conditions 8 Lymphoma 8 Uterine Cervical Neoplasms 6 Pancreatic Neoplasms 6 Leukemia 6 Esophageal Neoplasms 6 Colorectal Neoplasms 6 Colonic Neoplasms 6 Breast Neoplasms, Male 6 Urinary Bladder Neoplasms 5 Rectal Neoplasms 5 Myelodysplastic Syndromes 5 Lymphoma, Follicular 5 Leukemia, Myeloid, Acute 5 Leukemia, Lymphocytic, Chronic, B-Cell 5 Head and Neck Neoplasms 5 Barrett Esophagus 5 Adenocarcinoma Of Esophagus 5 Salivary Gland Neoplasms 4 Recurrence 4 Multiple Myeloma 4 Lymphoma, Non-Hodgkin 4

Interventions

3-fluoro-2-(4-((2-nitro-1H-imidazol-1-yl)methyl)-1H-1,2,3-triazol-1-yl)propan-1-ol 4 pimonidazole 2 TH 302 2 gadobutrol 1 fluoromisonidazole 1 Surgical Procedures, Operative 1 Sodium Chloride 1 Sevoflurane 1 Saline Solution 1 Radiotherapy 1 Propofol 1 Positron Emission Tomography Computed Tomography 1 Pancreaticoduodenectomy 1 Oxygen 1 NVP-BKM120 1 Ketamine 1 Gemcitabine 1 Ferrosoferric Oxide 1 Dexmedetomidine 1 Blood Specimen Collection 1 Biopsy 1 Bacterial Load 1 Atovaquone 1 3-(4-(2-fluoroethoxy)phenyl)-2-(3-methyl-2-(4-((2-sulfamoylbenzo(d)thiazol-6-yloxy)methyl)-1H-1,2,3-triazol-1-yl)butanamido)propanoic acid 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Hypoxia × Biopsy × Clear all

NCT02157246 2017-03-13

RHYTHM-I

University of Oxford

Phase NA Completed

Gastrointestinal

Hypoxia, Rectal Neoplasms

Data powered by HemOnc (CC BY 4.0) Colophon ⚡